필요한 CMO/CDMO 검색 및 찾기
귀하의 약물 개발 및 제조 프로젝트를 위한 고도로 숙련된 파트너를 찾아보세요.
시장: EMA (EU), FDA (USA)
서비스: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging
지역: 유럽
규정 준수: FDA (cGMP), ISO, IFS, EMA (EU GMP)
배치 크기: Large, Small, Medium
카테고리 / 제품: 화장품, 영양식품, FDF/의약품
사용: Human, Veterinary
OEB(직업 노출 밴딩): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
OEB(직업 노출 밴딩): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
시장: EMA (EU), ANVISA (Brazil), Russian Health Authorities, SFDA (Saudi Arabia)
지역: 유럽
규정 준수: ISO, Roszdravnadzor (Russia GMP), SFDA (Saudi Food & Drug Authority), EMA (EU GMP)
배치 크기: Large, Small, Medium
카테고리 / 제품: 화장품, FDF/의약품
사용: Human, Veterinary
서비스: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging
지역: 유럽
규제 물질: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse
시장: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), MHRA (UK)
지역: 유럽
규정 준수: FDA (cGMP), ISO, EMA (EU GMP)
배치 크기: Large, Small, Medium
사용: Human, Veterinary
서비스: Development services, Manufacturing services, Analytical / QC services
치료 전문 분야(ATC): (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (N) Nervous system
OEB(직업 노출 밴딩): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
카테고리 / 제품: FDF/의약품
시장: EMA (EU), FDA (USA)
지역: 유럽
규정 준수: FDA (cGMP), ISO, EMA (EU GMP), World Health Organization (GMP / HACCP)
배치 크기: Large, Small, Medium
카테고리 / 제품: 영양식품, 서비스, 입자공학
사용: Human, Veterinary
BSL(생물학적 안전 수준): 1, 2
서비스: Development services, Manufacturing services
OEB(직업 노출 밴딩): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
규제 물질: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse
시장: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), Russian Health Authorities, MHRA (UK), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, TGA (Australia)
지역: 유럽
배치 크기: Large, Small, Medium
사용: Human
서비스: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging
치료 전문 분야(ATC): (C) Cardiovascular system, (D) Dermatologicals, (J) Antiinfectives for systemic use, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (A) Digestive tract and metabolism
규정 준수: PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), TGA (Australia GMP), TITCK (Turkish Health Authorities), SFDA (Saudi Food & Drug Authority), EMA (EU GMP), Health Canada (Canada GMP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)
OEB(직업 노출 밴딩): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
카테고리 / 제품: 서비스, FDF/의약품
Adragos Pharma | Maisons-Alfort
Adragos Pharma
사전 충전형 주사기, 액체 및 동결건조 바이알을 전문으로 하는 이 회사는 고급 무균 충전, 동결 건조 및 검사 시스템을 결합합니다.
치료 전문 분야(ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (A) Digestive tract and metabolism
시장: EMA (EU), NMPA (China), ANVISA (Brazil), Russian Health Authorities, SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities
지역: 유럽
배치 크기: Large
사용: Human
BSL(생물학적 안전 수준): 1
서비스: Manufacturing services, Analytical / QC services, Regulatory services, Packaging
규제 물질: Lowest potential for abuse
규정 준수: ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), TITCK (Turkish Health Authorities), SFDA (Saudi Food & Drug Authority), NMPA (China GMP), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP)
카테고리 / 제품: FDF/의약품
OEB(직업 노출 밴딩): 1 / low-hazard (PDE > 10,000 µg/day)
규제 물질: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse
시장: EMA (EU), PMDA (Japan), NMPA (China), MHRA (UK), MFDS (South Korea)
서비스: Logistics, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
지역: 유럽
배치 크기: Large, Small, Medium
사용: Human, Veterinary
OEB(직업 노출 밴딩): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
규정 준수: EMA (EU GMP)
카테고리 / 제품: FDF/의약품
Adragos Pharma | Halden
Adragos Pharma
당사는 BFS(Blow-Fill-Seal) 기술 및 기타 제형을 사용하여 IV 백, 플라스틱 앰플 및 바이알 제조를 전문으로 합니다.
규제 물질: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse
시장: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), ANVISA (Brazil), MHRA (UK), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), TGA (Australia)
서비스: Logistics, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
지역: 유럽
규정 준수: FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), TGA (Australia GMP), TITCK (Turkish Health Authorities), UAE Ministry of Health & Prevention, NMPA (China GMP), EMA (EU GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP), NSF
배치 크기: Large, Small, Medium
사용: Human
치료 전문 분야(ATC): (D) Dermatologicals, (V06) Nutrients, (A) Digestive tract and metabolism
OEB(직업 노출 밴딩): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
카테고리 / 제품: FDF/의약품
OEB(직업 노출 밴딩): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
규제 물질: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse
시장: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), ANMAT (Argentina), SFDA (Saudi Arabia), MFDS (South Korea), EDE (UAE), CDSCO (India), TGA (Australia)
서비스: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
지역: 유럽
규정 준수: FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), UAE Ministry of Health & Prevention, NMPA (China GMP), EMA (EU GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP), NSF
배치 크기: Large, Small, Medium
사용: Human
카테고리 / 제품: 서비스, FDF/의약품
규제 물질: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse
시장: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), MHRA (UK), SFDA (Saudi Arabia), MFDS (South Korea), EDE (UAE), CDSCO (India), TGA (Australia)
서비스: Logistics, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
지역: APAC
규정 준수: FDA (cGMP), PMDA/MHLW (Japan GMP), EMA (EU GMP)
배치 크기: Large
사용: Human
OEB(직업 노출 밴딩): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
카테고리 / 제품: 서비스, FDF/의약품
시장: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), MHRA (UK), MFDS (South Korea)
서비스: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
지역: 유럽
규정 준수: FDA (cGMP), EMA (EU GMP)
사용: Human
규제 물질: High potential for abuse & no medical use
배치 크기: Small, Medium
OEB(직업 노출 밴딩): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
카테고리 / 제품: FDF/의약품